Preclinical pharmacokinetic/pharmacodynamic models of gefitinib and the design of equivalent dosing regimens in EGFR wild-type and mutant tumor models.

Source:http://linkedlifedata.com/resource/pubmed/id/18281523

Download in:

View as

General Info

PMID
18281523